HHLR Advisors’s BeOne Medicines Ltd ONC Stock Holding History

HHLR Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,034,306	Closed	-$307M	–	43
2026 Q1	$307M	Hold	1,034,306	–	–	18.36%	3
2025 Q4	$314M	Hold	1,034,306	–	–	10.12%	3
2025 Q3	$352M	Hold	1,034,306	–	–	8.61%	5
2025 Q2	$250M	Hold	1,034,306	–	–	8.06%	4
2025 Q1	$282M	Sell	1,034,306 -2,770,100	-73%	-$648M	7.95%	4
2024 Q4	$703M	Sell	3,804,406 -1,372,500	-27%	-$280M	24.34%	1
2024 Q3	$1.16B	Hold	5,176,906	–	–	25.52%	1
2024 Q2	$739M	Hold	5,176,906	–	–	18.22%	2
2024 Q1	$810M	Hold	5,176,906	–	–	17.58%	2
2023 Q4	$934M	Hold	5,176,906	–	–	18.82%	2
2023 Q3	$931M	Hold	5,176,906	–	–	20.79%	1
2023 Q2	$923M	Sell	5,176,906 -295,353	-5%	-$68M	19.66%	1
2023 Q1	$1.18B	Hold	5,472,259	–	–	20.91%	1
2022 Q4	$1.2B	Hold	5,472,259	–	–	25.41%	1
2022 Q3	$738M	Hold	5,472,259	–	–	19.4%	1
2022 Q2	$886M	Hold	5,472,259	–	–	18.98%	1
2022 Q1	$1.03B	Hold	5,472,259	–	–	21.55%	1
2021 Q4	$1.48B	Hold	5,472,259	–	–	22.91%	1
2021 Q3	$1.99B	Hold	5,472,259	–	–	25.98%	1
2021 Q2	$1.88B	Hold	5,472,259	–	–	19.33%	1
2021 Q1	$1.9B	Hold	5,472,259	–	–	18.82%	1
2020 Q4	$1.41B	Hold	5,472,259	–	–	11.24%	2
2020 Q3	$1.57B	Hold	5,472,259	–	–	11.87%	2
2020 Q2	$1.03B	Hold	5,472,259	–	–	9.42%	3
2020 Q1	$674M	Hold	5,472,259	–	–	9.08%	3
2019 Q4	$907M	Hold	5,472,259	–	–	11.3%	2
2019 Q3	$670M	Buy	5,472,259 +1,034,306	+23%	+$137M	9.21%	2
2019 Q2	$550M	Hold	4,437,953	–	–	12.3%	1
2019 Q1	$586M	Hold	4,437,953	–	–	16.32%	1
2018 Q4	$622M	Buy	+4,437,953	New	+$589M	25.82%	1

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HHLR Advisors's ONC Position: Q2 2026 in Review

HHLR Advisors sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 1,034,306 shares — an estimated $307M sold.

HHLR Advisors first reported a position in ONC in Q4 2018 and held it in 30 quarters. The position peaked at $1.99B in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

HHLR Advisors reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
HHLR Advisors sold 1,034,306 BeOne Medicines Ltd shares in Q2 2026, an estimated $307M.
HHLR Advisors first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 30 quarters.
HHLR Advisors's BeOne Medicines Ltd position peaked at $1.99B in Q3 2021.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on HHLR Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.